Le Lézard
Classified in: Health
Subjects: PER, DIS, SCZ, DEI

Help at Home Announces Appointment of Dr. Christina Jenkins to Board of Directors


New board addition adds robust and diverse expertise across the health care continuum

CHICAGO, Ill., March 15, 2022 /PRNewswire/ -- Help at Home, a leading national provider of in-home, person-centered care for seniors, announced the appointment of Christina Jenkins, MD, to its board of directors.

"I am excited to have Dr. Jenkins join our board of directors. She brings a wide range of health and value-based care, as well as technology platform experience, which will deepen the board's depth and breadth in areas critical to driving our company's evolution," said Chief Executive Officer Chris Hocevar. "Dr. Jenkins joins a world-class board with the goal to accelerate the delivery of a more holistic model, transforming in-home care services for seniors and must-serve populations, providing them with Great Days and Meaningful Moments at home."

Dr. Christina Jenkins, MD ("CJ"), is a venture investor and strategic adviser who uses technology and trusted relationships to improve health, at scale. She is a Venture Partner at Phoenix Venture Partners, leading investments in seed and early-stage digital health and hardware-enabled platform companies used for diagnosis or monitoring. Dr. Jenkins serves on the boards of several venture-backed companies, is a board advisor to Independence Health Group (parent of Independence Blue Cross and Amerihealth Caritas) and advises C-suite health care leaders in health system redesign, integrated care strategies and clinical value improvement.

Previously, she was the founding CEO of OneCity Health, a population-health focused subsidiary of NYC Health and Hospitals, the nation's largest public hospital system. There, she led a $1.2B effort to accelerate value-based payment readiness for 1M low-income New Yorkers through effecting novel tech platforms and integrated care models across the care continuum. She was a Bloomberg appointee to the board of NYC Health and Hospitals, serving as board chair of its Quality and Performance Committee, and a member of the Quality Committee of Healthfirst, a 1.2M member health plan. Dr. Jenkins is a former practicing internist trained at Mount Sinai in New York, where she served as a clinical instructor in medicine. She is a member of the Kauffman Fellows, a global leadership network of venture capitalists. Dr. Jenkins earned her M.D. from Northwestern University and her B.S. in Industrial Management from Purdue University.

About Help at Home
Help at Home is a leading national provider of in-home care services, delivering high-quality, relationship-based personal care and other services to help seniors and the disabled remain in their homes, the preferred setting of care. During the fourth quarter of 2021, Help at Home provided in-home, community-based services to an average of 52,000 monthly clients serving more than 160 branch locations across 11 states with the help of more than 30,000 highly trained caregivers. For more information about Help at Home, visit www.helpathome.com.

Kristen Trenaman                                          
VP of Public Relations
[email protected]
Contact: 502-445-4126

SOURCE Help at Home


These press releases may also interest you

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...



News published on and distributed by: